Understanding how cystic fibrosis mutations cause a loss of Cl- channel function

Molecular Medicine Today

Volumn 2, Issue 7, 1996, Pages 290-297

  Sheppard, David N ^a   Ostedgaard, Lynda S ^b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CFTR PROTEIN, HUMAN; CHLORIDE; TRANSMEMBRANE CONDUCTANCE REGULATOR;

CHEMICAL STRUCTURE; CYSTIC FIBROSIS; GENETICS; GENOTYPE; HUMAN; METABOLISM; MUTATION; PATCH CLAMP; REVIEW;

CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; GENOTYPE; HUMANS; MODELS, MOLECULAR; MUTATION; PATCH-CLAMP TECHNIQUES;

EID: 0030187146     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)10028-9     Document Type: Review

References (45)

1. Welsh, M.J., Tsui, L-C., Boat, T.F. and Beaudet, A.L. (1995) Cystic fibrosis, in The Metabolic Basis of Inherited Disease (7th edn) (Scriver, C.R., Beaudet, A.L., Sly, W.S. and Valle, D., eds), pp. 3799-3876, McGraw-Hill
2. Quinton, P.M. (1990) Cystic fibrosis: a disease in electrolyte transport, FASEB J. 4, 2709-2717
3. Riordan. J.R. et al. (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA, Science 245, 1066-1073
4. Ames, G.F-L., Mimura, C.S. and Shyamala, V. (1990) Bacterial periplasmic permeases belong to a family of transport proteins operating from Escherichia coli to human: traffic ATPases, FEMS Microbiol. Rev. 75, 429-446
5. Hyde, S.C. et al. (1990) Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport, Nature 346, 362-365
6. Kristidis, P. et al. (1992) Genetic determination of exocrine pancreatic function in cystic fibrosis, Am. J. Hum. Genet. 50, 1178-1184
7. Drumm, M.L. et al. (1991) Chloride conductance expressed by ΔF508 and other mutant CFTRs in Xenopas oocytes, Science 254, 1797-1799
8. Cheng, S.H. et al. (1990) Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis, Cell 63, 827-834
9. - channels with altered pore properties, Nature 362, 160-164
10. Find, S., Riordan, J.R. and Williams, D.B. (1994) Participation of the endoplasmic reticulum chaperone calnexin (p88, IP90) in the biogenesis of the cystic fibrosis transmembrane conductance regulator, J. Biol. Chem. 269, 12784-12788
11. Yang, Y., Janich, S., Cohn, J.A. and Wilson, J.M. (1993) The common variant of cystic fibrosis transmembrane conductance regulator is recognized by hsp70 and degraded in a pre-Golgi nonlysosomal compartment, Proc. Natl. Acad. Sci. U. S. A. 90, 9480-9484
12. Ward, C.L. and Kopito, R.R. (1994) Intracellular turnover of cystic fibrosis transmembrane conductance regulator. Inefficient processing and rapid degradation of wild-type and mutant proteins, J. Biol. Chem. 269, 25710-25718
13. Lukacs, G.L. et al. (1994) Conformational maturation of CFTR but not its mutant counterpart (ΔF508) occurs in the endoplasmic reticulum and requires ATP, EMBO J. 13, 6076-6086
14. Ward, C.L., Omura, S. and Kopito, R.R. (1995) Degradation of CFTR by the ubiquitin-proteasome pathway, Cell 83, 121-127
15. Jensen, T.J. et al. (1995) Multiple proteolytic systems, including the proteasome, contribute to CFTR processing, Cell 83, 129-135
16. Denning, G.M. et al. (1992) Processing of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764
17. Li, C. et al. (1993) The cystic fibrosis mutation (ΔF508) does not influence the chloride channel activity of CFTR, Nat. Genet. 3, 311-316
18. - channel is functional when retained in endoplasmic reticulum of mammalian cells, J. Biol. Chem. 270, 12347-12350
19. Sheppard, D.N., Ostedgaard, L.S., Winter, M.C. and Welsh, M.J. (1995) Mechanism of dysfunction of two nucleotide binding domain mutations in cystic fibrosis transmembrane conductance regulator that are associated with pancreatic sufficiency, EMBO J. 14, 876-883
20. Harmill, O.P. et al. (1981) Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches, Pflügers Arch. 391, 85-100
21. Tabcharani, J.A. et al. (1993) Multi-ion pore behaviour in the CFTR chloride channel, Nature 366, 79-82
22. Akabas, M.H., Kaufmann, C., Cook, T.A. and Archdeacon, P. (1994) Amino acid residues lining the chloride channel of the cystic fibrosis transmembrane conductance regulator, J. Biol. Chem. 269, 14865-14868
23. Champigny, G. et al. (1995) A change in gating mode leading to increased intrinsic CT channel activity compensates for defective processing in a cystic fibrosis mutant corresponding to a mild form of the disease, EMBO J. 14, 2417-2423
24. Can, K-H. el al. (1995) A cystic fibrosis mutation associated with mild lung disease, New Engl. J. Med. 333, 95-99
25. Clarke, L.L. et al. (1994) Relationship of a non-cystic fibrosis transmembrane conductance regulator-mediated chloride conductance to organ-level disease in Cftr(-/-) mice, Proc. Natl. Acad. Sci. U. S. A. 91, 479-483
26. Stutts, M.J. et al. (1995) CFTR as a cAMP-dependent regulator of sodium channels, Science 269, 847-850
27. Higgins, C.F. (1995) The ABC of channel regulation, Cell 82, 693-696
28. Fulmer, S.B. et al. (1995) Two cystic fibrosis transmembrane conductance regulator mutations have different effects on both pulmonary phenotype and regulation of outwardly reclined chloride currents, Proc. Natl. Acad. Sci. U. S. A. 92, 6832-6836
29. Wilson, J.M. (1995) Gene therapy for cystic fibrosis: challenges and future directions, J. Clin. Invest. 96, 2547-2554
30. Ramjeesingh, M. et al. (1995) Treatment of the nasal epithelium of CF mice with liposomes containing purified CFTR protein, Pediatr. Pulmonol. (Suppl.) 12, S10.7.
31. Cheng, S.H. et al. (1995) Functional activation of the cystic fibrosis trafficking mutant ΔF508-CFTR by overexpression, Am. J. Physiol. 268, L615-L624
32. Brown, C.R. et al. (1995) Glycerol treatments result in the proper processing and function of the CFTR protein, Pediatr. Pulmonol. (Suppl.) 12, S20.6
33. Sato, S. et al. (1996) Glycerol reverses the misfolding phenotype of the most common cystic fibrosis mutation, J. Biol. Chem. 271, 635-638
34. Bradbury, N.A. and Bridges, R.J. (1995) Regulation of vesicular associated CFTR trafficking, Pediatr. Pulmonol. (Suppl.) 12, 117-118
35. Dramm, M.L. and Kelley, T.J. (1995) Inhibition of specific phosphodiesterases in CF airway epithelial cells activates mutant CFTRs, Pediatr. Pulmonol. (Suppl.) 12, 150-151
36. - channel in CHO cells stably expressing the cystic fibrosis gene, Nature 352, 628-631
37. - channels by the tyrosine kinase inhibitor genistein, Am. J. Physiol. 268, C886-C893
38. Becq, F. et al. (1994) Phosphatase inhibitors activate normal and defective CFTR chloride channels, Proc. Natl. Acad. Sci. U. S. A. 91, 9160-9164
39. - channel gating to an ATP hydrolysis cycle, Neuron 12, 473-482
40. Gunderson, K.L. and Kopito, R.R. (1994) Effects of pyrophosphate and nucleotide analogs suggest a role for ATP hydrolysis in cystic fibrosis transmembrane regulator channel gating, J. Biol. Chem. 269, 19349-19353
41. Carson, M.R., Winter, M.C., Travis, S.M. and Welsh, M.J. (1995) Pyrophosphate stimulates wild-type and mutant cystic fibrosis transmembrane conductance regulator CT channels, J. Biol. Chem. 270, 20466-20472
42. Gribkoff, V.K. et al. (1994) The substituted benzunidazolone NS004 is an opener of the cystic fibrosis chloride channel, J. Biol. Chem. 269, 10983-10986
43. 1 adenosine-receptor antagonists activate chloride efflux from cystic fibrosis cells, Proc. Natl. Acad. Sci. U. S. A. 89, 5562-5566
44. Mason, S.J., Paradiso, A.M. and Boucher, R.C. (1991) Regulation of transepithelial ion transport and intracellular calcium by extracellular ATP in human normal and cystic fibrosis airway epithelium, Br. J. Pharmacol. 103, 1649-1656
45. Knowles, M.R., Clarke, L.L. and Boucher, R.C. (1991) Activation by extracellular nucleotides of chloride secretion in the airway epithelia of patients with cystic fibrosis, New Engl. J. Med. 325, 533-538